Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/122654

In Collections

This item can be found in the following collections:

Dugel, P.U.; Koh, A.; Ogura, Y.; Jaffe, G.J.; Schmidt-Erfurth, U.; Brown, D.M.; ... ; HARRIER Study Investigator (2019)

Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print]) Reply

Article / Letter to editor
All authors
Dugel, P.U.; Koh, A.; Ogura, Y.; Jaffe, G.J.; Schmidt-Erfurth, U.; Brown, D.M.; Gomes, A.V.; Warburton, J.; Weichselberger, A.; Holz, F.G.; HAWK Study Investigator; HARRIER Study Investigator
Date
2019-12-01
Volume
126
Issue
12
Pages
E96 - E97
DOI
doi:10.1016/j.ophtha.2019.08.016